Ocular surface changes and risk factors in patients with type 2 diabetes mellitus

Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 12

Abstract

AIM: To analyze ocular surface changes and risk factors in patients with type 2 diabetes mellitus(T2DM). <p>METHODS: Totally 118 cases of T2DM patients(236 eyes)admitted from May 2017 to May 2018 were selected as T2DM group, and 100 non-T2DM patients(200 eyes)were selected as control group. The patients were given routine ophthalmic testing, Schirmer Ⅰ test(SⅠt), tear film break-up test(BUT), corneal fluorescein staining test(FL)and conjunctive impression cytology. The cases data were collected for univariate and multivariate Logistic regression analysis so as to analyze the independent risk factors for ocular surface changes in T2DM patients. <p>RESULTS: The incidence rate of ocular surface changes in T2DM group was significantly higher than that in control group(22.5% <i>vs</i> 7.5%,<i> P</i><0.05). The SⅠt, BUT and conjunctival goblet cell count in T2DM group were significantly lower than those in control group while the FL and conjunctival squamous metaplasia degree were significantly higher than those in control group(<i>P</i><0.05). Univariate analysis results suggested that there were significantly differences between T2DM patients with ocular surface changes and T2DM patients without ocular surface changes in terms of age, disease duration, fasting plasma glucose(FPG), plasma total cholesterol(TC), triglycerides(TG), low-density lipoprotein cholesterol(LDL-C), glycosylated hemoglobin(HbA1c), urea, creatinine(Cr), glomerular filtration rate(GFR)and 24h urinary protein(24h UP)(<i>P</i><0.05). Multivariate Logistic regression analysis showed age, disease duration, TC, TG, LDL-C, HbA1c and Cr were independent risk factors for ocular surface changes in T2DM patients. <p>CONCLUSION: Ocular surface changes of T2DM patients are more obvious than those of normal people, and T2DM patients have high incidence of ocular surface changes, thus it is necessary to actively correct lipid metabolism disorder and given early prevention for T2DM patients so as to reduce the risk of ocular surface changes.

Authors and Affiliations

Zhong-Ling Zeng

Keywords

Related Articles

Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy

AIM: To probe into the related influencing factors of serum lipoprotein associated phospholipase A2(Lp-PLA2)level in patients with diabetic retinopathy. <p>METHODS: Totally 174 cases of patients with type 2 diabetes mell...

Correlation between infection with demodex folliculorum of eyelash and Meibomian gland dysfunction in elderly patients

AIM:To investigate the prevalence of demodex folliculorum in eyelashes of elderly patients with Meibomian gland dysfunction(MGD)and to find the correlation between the presence of demodex folliculorum and MGD. <p>METHODS...

Protective effect of nerve growth factor combined with mecobalamine on optic nerve and influence on MMP-2 and TIMP-2

AIM: To investigate the protective effect of nerve growth factor(NGF)combined with mecobalamine on optic nerve and the influence on matrix metalloproteinase-2(MMP-2), tissue inhibitor of matrix metalloprotease-2(TIMP-2)....

Effects of amniotic membrane transplantation combined with limbal stem cell autograft transplantation on ocular burns

AIM: To investigate the effects of amniotic membrane transplantation combined with limbal stem cell autograft transplantation on ocular surface repair time, repair rate and complications in patients with ocular burns. <p...

Vitrectomy combine with double membranes peeling for idiopathic epiretinal membrane

AIM: To explore the efficacy and safety of vitrectomy combine with internal limiting membrane peeling and epiretinal membranes peeling in the treatment of idiopathic epiretinal membrane(IERM). <p>METHODS: In this retrosp...

Download PDF file
  • EP ID EP501822
  • DOI 10.3980/j.issn.1672-5123.2018.12.39
  • Views 126
  • Downloads 0

How To Cite

Zhong-Ling Zeng (2018). Ocular surface changes and risk factors in patients with type 2 diabetes mellitus. Guoji Yanke Zazhi, 18(12), -. https://europub.co.uk./articles/-A-501822